Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

France launches massive HIV prevention study to curb new infections

NCT ID NCT03795376

Prevention Sponsor: DatAids Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking how HIV prevention is done across 23 clinics in France, including overseas territories. Researchers will collect data on HIV testing, STI and hepatitis screening, and the use of prevention pills (PrEP) and emergency treatment (PEP). The goal is to understand who is using these services and how well they work, with 6,500 HIV-negative adults expected to take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could provide valuable insights to improve HIV prevention strategies and reduce new infections in France.
What could go wrong
This is an observational study, not a treatment trial. It collects data but does not test a new drug or intervention, so direct health benefits for participants are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 6,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2019

Expected to finish

Jan 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All persons attending for HIV prevention and seeking care at 23 centers using NADIS are included in the Dataids Prevention cohort after receiving oral information and giving written consent. NADIS is an electronic medical record (EMR) for HIV infection (and Hepatitis B virus (HBV), Hepatitis C virus (HCV), STI) and HIV prevention in French public hospitals. The Dataids Prevention study recruits persons HIV- and above the age of 18 years.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male and female over 18 years old, * HIV negative * Attending for : * HIV screening * Hepatitis screening * STI screening / treatment * Blood, body fluid or sexual exposure * Post-exposure prophylaxis * Pre-exposure prophylaxis * Signed consent Exclusion Criteria: * HIV-infection * Refusal to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV prevention

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    31 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Bretagne-Atlantique

    RECRUITING

    Vannes, France

  • CH Nîmes

    RECRUITING

    Nîmes, France

  • CHD Vendée

    RECRUITING

    La Roche-sur-Yon, France

  • CHR Metz-Thionville

    RECRUITING

    Metz, France

  • CHR Orléans

    RECRUITING

    Orléans, France

  • CHRU Brest

    RECRUITING

    Brest, France

  • CHU Besançon - Hôpital Jean Minjoz

    RECRUITING

    Besançon, France

  • CHU Clermont-Ferrand - Hôpital Gabriel-Montpied

    RECRUITING

    Clermont-Ferrand, France

  • CHU Limoges

    RECRUITING

    Limoges, France

  • CHU Nancy - Hôpital Brabois

    RECRUITING

    Nancy, France

  • CHU Nantes - Hôtel-Dieu

    RECRUITING

    Nantes, France

  • CHU Nice - Hôpital l'Archet

    RECRUITING

    Nice, France

  • CHU Reims - Hôpital Robert Debré

    RECRUITING

    Reims, France

  • CHU Rennes - Hôpital Pontchaillou

    RECRUITING

    Rennes, France

  • CHU Rouen

    RECRUITING

    Rouen, France

  • CHU St Etienne - Hôpital Nord

    RECRUITING

    Saint-Etienne, France

  • CHU Strasbourg - Hôpital Civil

    RECRUITING

    Strasbourg, France

  • CHU Toulouse - Hôpital Purpan

    RECRUITING

    Toulouse, France

  • CHU Tourcoing - Hôpital Guy Chatiliez

    RECRUITING

    Tourcoing, France

  • CHU de Guadeloupe

    RECRUITING

    Pointe-à-Pitre, Guadeloupe

  • CHU de Martinique

    RECRUITING

    Fort-de-France, Martinique

  • Centre Hospitalier de Cornouaille

    RECRUITING

    Quimper, France

  • Groupe Hospitalier Pitié Salpêtrière - Assistance Publique des Hôpitaux de Paris

    RECRUITING

    Paris, France

  • Hôpital Bichat - Assistance Publique des Hôpitaux de Paris

    RECRUITING

    Paris, France

  • Hôpital Bicêtre - Assistance Publique des Hôpitaux de Paris

    RECRUITING

    Le Kremlin-Bicêtre, France

  • Hôpital Gui de Chauliac

    RECRUITING

    Montpellier, France

  • Hôpital Necker-Pasteur - Assistance Publique des Hôpitaux de Paris

    RECRUITING

    Paris, France

  • Hôpital Nord Franche Comté

    RECRUITING

    Belfort, France

  • Hôpital Sainte Marguerite - Assistance Publique des Hôpitaux de Marseille

    RECRUITING

    Marseille, France

  • Hôpital de la Croix-Rousse - Hospices Civils de Lyon

    RECRUITING

    Lyon, France

  • IHU - Assistance Publique des Hôpitaux de Marseille

    RECRUITING

    Marseille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.